Tavia Acquisition Corp. and Vita Inclinata Technologies Sign Letter of Intent to go public on NASDAQ
London, United Kingdom, July 13, 2026 (GLOBE NEWSWIRE) -- Tavia Acquisition Corp. (Nasdaq: TAVI) ("Tavia") and Vita Inclinata Technologies, Inc. ("Vita") today announced they have signed a Letter of…
Read the full articleYou might also wanna read
Vita Inclinata Technologies to Go Public Through SPAC Deal
Vita Inclinata Technologies, a maker of safety-technology products, plans to go public on Nasdaq through a deal with a special purpose acqui
Tavia Acquisition (TAVIU) Moves Toward Public Listing with Vita Inclinata
Related Stocks: TAVIU
Attovia Therapeutics files for Nasdaq IPO to fund immune-disease biologics
Tao Fu's San Carlos biotech is seeking an ATTO listing before disclosing price range, share count or valuation.
Iovance Biotherapeutics (NASDAQ:IOVA) jumps 18%, adding a cash balance to its market value
NEW YORK, July 15, 2026, 15:08 EDT Iovance Biotherapeutics (NASDAQ:IOVA) shares surged 18.2% to $4.645 by 3:01 p.m. EDT on Wednesday, adding
Two more biotechs, Attovia and Braveheart, join the IPO line
Two more biotechs, Attovia and Braveheart, join the IPO line Phil.Taylor Thu, 16/07/2026 - 10:13
Navitas Semiconductor stock surges on AI data center hopes, trades well above analyst targets
A small power-chip company that most investors never tracked closely is now one of the most argued-over names on the Nasdaq.
bit.ly·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.